{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:26:27Z","timestamp":1770506787576,"version":"3.49.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Background: Hyperhomocysteinemia is an independent, graded risk factor for coronary artery disease (CAD). The G894T variant of endothelial nitric oxide synthase (eNOS) was postulated to be associated with hyperhomocysteinemia and could influence individual susceptibility to CAD. The aims of this study were to investigate (a) the relationship of the eNOS G894T polymorphism with the presence and the severity of CAD and (b) the possible relationship between hyperhomocysteinemia and the eNOS G894T variant for the risk of CAD severity in a Tunisian population.<\/jats:p>\n               <jats:p>Methods: We used PCR with restriction fragment length polymorphism analysis to detect the G894T variant of the eNOS gene in 100 patients with CAD and 120 healthy controls. The severity of CAD was expressed by the number of affected vessels. Total plasma homocysteine concentrations were determined by direct chemiluminescence assay.<\/jats:p>\n               <jats:p>Results: The frequencies of the eNOS GG, GT, and TT genotypes in the CAD group were significantly different from those in the control group (45%, 44%, and 11% vs 60%, 35.8% and 4.2%, respectively; P = 0.035). There was no association between the eNOS G894T genotype frequencies and the number of stenosed vessels (P = 0.149). In the CAD group, the coexistence of the 894 GT or TT genotypes and hyperhomocysteinemia led to an increased risk of CAD severity.<\/jats:p>\n               <jats:p>Conclusion: The G894T polymorphism of the eNOS gene is associated with the presence of CAD, and in conjunction with hyperhomocysteinemia, increased the risk of CAD severity in a Tunisian population.<\/jats:p>","DOI":"10.1373\/clinchem.2005.057950","type":"journal-article","created":{"date-parts":[[2005,11,11]],"date-time":"2005-11-11T01:25:25Z","timestamp":1131672325000},"page":"53-58","source":"Crossref","is-referenced-by-count":38,"title":["Hyperhomocysteinemia, Endothelial Nitric Oxide Synthase Polymorphism, and Risk of Coronary Artery Disease"],"prefix":"10.1093","volume":"52","author":[{"given":"Mohsen","family":"Kerkeni","sequence":"first","affiliation":[{"name":"Research Unit 03\/UR\/08-14, Faculty of Pharmacy, Monastir, Tunisia"},{"name":"Department of Cardiology, CHU Fattouma Bourguiba, Monastir, Tunisia"},{"name":"Department of Biochemistry, Hospital Saint-Joseph, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faouzi","family":"Addad","sequence":"first","affiliation":[{"name":"Department of Cardiology, CHU Fattouma Bourguiba, Monastir, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryline","family":"Chauffert","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Hospital Saint-Joseph, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Myara","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Hospital Saint-Joseph, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Ben Farhat","sequence":"first","affiliation":[{"name":"Department of Cardiology, CHU Fattouma Bourguiba, Monastir, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelhedi","family":"Miled","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Toxicology, CHU Hached, Sousse, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khira","family":"Maaroufi","sequence":"first","affiliation":[{"name":"Research Unit 03\/UR\/08-14, Faculty of Pharmacy, Monastir, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franc\u0327ois","family":"Trivin","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Hospital Saint-Joseph, Paris, France"},{"name":"Department of Biochemistry and Toxicology, CHU Hached, Sousse, Tunisia"},{"name":"Department of Clinical Biochemistry, Franc\u0327ois Rabelais University, Tours, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,1,1]]},"reference":[{"key":"2020022801102348200_R1","doi-asserted-by":"crossref","unstructured":"Gotto AM. Interactions of the major risk factors for coronary heart disease. Am J Med1986;80:48-55.","DOI":"10.1016\/0002-9343(86)90160-9"},{"key":"2020022801102348200_R2","doi-asserted-by":"crossref","unstructured":"Kannel WB. Clinical misconceptions dispelled by epidemiological research. Circulation1995;92:3350-3360.","DOI":"10.1161\/01.CIR.92.11.3350"},{"key":"2020022801102348200_R3","doi-asserted-by":"crossref","unstructured":"Wilson PW, D\u2019Agastino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB, et al. Prediction of coronary heart disease using risk factors categories. Circulation1998;97:1837-1847.","DOI":"10.1161\/01.CIR.97.18.1837"},{"key":"2020022801102348200_R4","doi-asserted-by":"crossref","unstructured":"Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med1994;330:1041-1046.","DOI":"10.1056\/NEJM199404143301503"},{"key":"2020022801102348200_R5","doi-asserted-by":"crossref","unstructured":"Boerwinkle E, Ellsworth DL, Hallman DM, Biddinger A. Genetic analysis of atherosclerosis: a research paradigm for the common diseases. Hum Mol Genet1996;5:1405-1410.","DOI":"10.1093\/hmg\/5.Supplement_1.1405"},{"key":"2020022801102348200_R6","doi-asserted-by":"crossref","unstructured":"Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. [Review]N Engl J Med1990;323:27-36.","DOI":"10.1056\/NEJM199007053230106"},{"key":"2020022801102348200_R7","doi-asserted-by":"crossref","unstructured":"Moncada S, Higgs A. The l-arginine-nitric oxide pathway. [Review]N Engl Med1993;329:2002-2012.","DOI":"10.1056\/NEJM199312303292706"},{"key":"2020022801102348200_R8","doi-asserted-by":"crossref","unstructured":"Schmidt HH, Walter U. NO at work. Cell1994;78:919-925.","DOI":"10.1016\/0092-8674(94)90267-4"},{"key":"2020022801102348200_R9","doi-asserted-by":"crossref","unstructured":"Danishpajooh IO, Gudi T, Chen Y, Kharitonov VG, Sharma VS, Boss GR. Nitric oxide inhibits methionine synthase activity in vivo and disrupts carbon flow through the folate pathway. J Biol Chem2001;276:27296-27303.","DOI":"10.1074\/jbc.M104043200"},{"key":"2020022801102348200_R10","doi-asserted-by":"crossref","unstructured":"Juckett MB, Weber M, Balla J, Jacob HS, Vercellotti GM. Nitric oxide donors modulate ferritin and protect endothelium from oxidative injury. Free Radic Biol Med1996;20:63-73.","DOI":"10.1016\/0891-5849(95)02024-1"},{"key":"2020022801102348200_R11","doi-asserted-by":"crossref","unstructured":"Suh JR, Oppenheim EW, Girgris S, Stover PJ. Purification and properties of folate-catabolizing enzyme. J Biol Chem2000;275:35646-35655.","DOI":"10.1074\/jbc.M005864200"},{"key":"2020022801102348200_R12","doi-asserted-by":"crossref","unstructured":"Durand P, Prost M, Loreau N, Lussier-Cacan S, Blache D. Impaired homocysteine metabolism and atherothrombotic disease. [Review]Lab Invest2001;81:645-672.","DOI":"10.1038\/labinvest.3780275"},{"key":"2020022801102348200_R13","doi-asserted-by":"crossref","unstructured":"Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med1991;324:1149-1155.","DOI":"10.1056\/NEJM199104253241701"},{"key":"2020022801102348200_R14","doi-asserted-by":"crossref","unstructured":". Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA2002;288:2015-2022.","DOI":"10.1001\/jama.288.16.2015"},{"key":"2020022801102348200_R15","doi-asserted-by":"crossref","unstructured":"Cayatte AJ, Polacino JJ, Horten K, Cohen RA. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb1994;14:753-759.","DOI":"10.1161\/01.ATV.14.5.753"},{"key":"2020022801102348200_R16","doi-asserted-by":"crossref","unstructured":"Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudgo GH, Alexander RW, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med1986;315:1046-1051.","DOI":"10.1056\/NEJM198610233151702"},{"key":"2020022801102348200_R17","doi-asserted-by":"crossref","unstructured":"Yashimura M, Yassue H, Nakayama M, Shimaski Y, Sumida H, Sugiyama S, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet1998;103:65-69.","DOI":"10.1007\/s004390050785"},{"key":"2020022801102348200_R18","doi-asserted-by":"crossref","unstructured":"Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, et al. A common variant of the endothelial nitric oxide synthase (Glu298Asp) is a major risk for coronary artery disease in the UK. Circulation1999;100:1515-1520.","DOI":"10.1161\/01.CIR.100.14.1515"},{"key":"2020022801102348200_R19","doi-asserted-by":"crossref","unstructured":"Vallet-Colom I, Levy-Marchal C, Zarrouk D, Tichet J, Krishnamoorty R, Czermichow P, et al. HLA-DQ B1 codon 57 and genetic susceptibility to type I (insulin-dependent) diabetes mellitus in French children. Diabetologia1990;33:174-176.","DOI":"10.1007\/BF00404046"},{"key":"2020022801102348200_R20","doi-asserted-by":"crossref","unstructured":"Ou T, Yamakawa-Kobayashi K, Arinami T, Amemiya H, Fujiwara H, Kawata K, et al. Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study. Atherosclerosis1998;137:23-28.","DOI":"10.1016\/S0021-9150(97)00244-X"},{"key":"2020022801102348200_R21","doi-asserted-by":"crossref","unstructured":"Gardemann A, Weidemann H, Philipp M, Katz N, Tillmanns H, Wilhelm Hehrlein F, et al. The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease. Eur Heart J1999;20:584-592.","DOI":"10.1053\/euhj.1998.1340"},{"key":"2020022801102348200_R22","doi-asserted-by":"crossref","unstructured":"Lembo G, De Luca N, Battagli C, Iovino G, Aretini A, Musicco M, et al. A common variant of the endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke2001;32:735-740.","DOI":"10.1161\/01.STR.32.3.735"},{"key":"2020022801102348200_R23","doi-asserted-by":"crossref","unstructured":"Szolnoki Z, Havasi V, Bene J, Komlosi K, Szoke D, Somogyvari F, et al. Endothelial nitric oxide synthase gene interactions and the risk of ischaemic stroke. Acta Neurol Scand2005;111:29-33.","DOI":"10.1111\/j.1600-0404.2004.00345.x"},{"key":"2020022801102348200_R24","doi-asserted-by":"crossref","unstructured":"Shimasaki Y, Yasue H, Yashimura M, Nakayama M, Kugiyama K, Ogawa H, et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol1998;31:1506-1510.","DOI":"10.1016\/S0735-1097(98)00167-3"},{"key":"2020022801102348200_R25","doi-asserted-by":"crossref","unstructured":"Heil SG, Den Hajer M, Van der rijt-pisa BJM, Kluijtmans LA, Blom HJ. The G894T variant of endothelial nitric oxide synthase (eNOS) increases the risk of recurrent venous thrombosis through interaction with elevated homocysteine levels. J Thromb Haemost2004;2:750-753.","DOI":"10.1111\/j.1538-7836.2004.00701.x"},{"key":"2020022801102348200_R26","doi-asserted-by":"crossref","unstructured":"Hibi K, Lshigami T, Tamura K, Mizushima S, Nyui N, Fujita T, et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension1998;32:521-526.","DOI":"10.1161\/01.HYP.32.3.521"},{"key":"2020022801102348200_R27","doi-asserted-by":"crossref","unstructured":"Casas JP, Bautista LE, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation2004;109:1359-1365.","DOI":"10.1161\/01.CIR.0000121357.76910.A3"},{"key":"2020022801102348200_R28","doi-asserted-by":"crossref","unstructured":"Cai H, Wilken DE, Wang XL. The Glu298Asp (G894T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J Mol Med1999;77:511-514.","DOI":"10.1007\/s001099900020"},{"key":"2020022801102348200_R29","doi-asserted-by":"crossref","unstructured":"Granath B, Taylor RR, Van Bockxmeer FM, Mamotte CD. Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the Australian Caucasian population. J Cardiovasc Risk2001;8:235-241.","DOI":"10.1177\/174182670100800408"},{"key":"2020022801102348200_R30","unstructured":"Wang CL, Hsu LA, Ko YS, Ko YL, Lee YH. Lack of association between the Glu298Asp variant of the endothelial nitric oxide synthase gene and the risk of coronary artery disease among Taiwanese. J Formos Med Assoc2001;100:736-740."},{"key":"2020022801102348200_R31","doi-asserted-by":"crossref","unstructured":"Schmoelzer I, Renner W, Paulweber B, Malaimare L, Iglseder B, Schmid P, et al. Lack of association between the Glu298Asp polymorphism of endothelial nitric oxide synthase with manifest coronary artery disease, carotid atherosclerosis and forearm vascular reactivity in two Austrian populations. Eur J Clin Invest2003;33:191-198.","DOI":"10.1046\/j.1365-2362.2003.01108.x"},{"key":"2020022801102348200_R32","doi-asserted-by":"crossref","unstructured":"Colombo MG, Andreassi MG, Paradossi U, Botto N, Manfredi S, Masetti S, et al. Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart2002;87:525-528.","DOI":"10.1136\/heart.87.6.525"},{"key":"2020022801102348200_R33","doi-asserted-by":"crossref","unstructured":"Colombo MG, Paradossi U, Andreassi MG, Botto N, Manfredi S, Masetti S, et al. Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem2003;49:389-395.","DOI":"10.1373\/49.3.389"},{"key":"2020022801102348200_R34","doi-asserted-by":"crossref","unstructured":"Agema WRP, Maat MPM, Zwinderman AH, Kastelein JJP, Rabelink TJ, Boven AJ, et al. An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in men. Clin Sci2004;107:255-261.","DOI":"10.1042\/CS20030360"},{"key":"2020022801102348200_R35","doi-asserted-by":"crossref","unstructured":"Yoon S, Shin C, Park HY, Moon J, Kim E, Kim HT, et al. Endothelial nitric oxide synthase gene is associated with vessel stenosis in Korean population. Clin Chim Acta2005;353:177-185.","DOI":"10.1016\/j.cccn.2004.10.018"},{"key":"2020022801102348200_R36","doi-asserted-by":"crossref","unstructured":"Brown KS, Kluijtmans LAJ, Young IS, Woodside J, Yarnell JWG, McMaster D, et al. Genetic evidence that nitric oxide modulates homocysteine, the NOS3 894TT genotype is a risk factor for hyperhomocysteinemia. Arterioscler Thromb Vasc Biol2003;23:1014-1020.","DOI":"10.1161\/01.ATV.0000071348.70527.F4"},{"key":"2020022801102348200_R37","doi-asserted-by":"crossref","unstructured":"Fisher PA, Dominguez GN, Cuniberti LA, Martinez V, Werba JP, Ramirez AJ, et al. Hyperhomocysteinemia induces renal hemodynamic dysfunction: is nitric oxide involved?. [Review]J Am Soc Nephrol2003;14:653-660.","DOI":"10.1097\/01.ASN.0000053419.27133.23"},{"key":"2020022801102348200_R38","doi-asserted-by":"crossref","unstructured":"Stanger O, Weger M. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium. Clin Chem Lab Med2003;41:1444-1454.","DOI":"10.1515\/CCLM.2003.222"},{"key":"2020022801102348200_R39","doi-asserted-by":"crossref","unstructured":"Dayal S, Arming E, Bottiglieri T, Boger RH, Sigmund CD, Faraci FM, et al. Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemia mice. Stroke2004;35:1957-1962.","DOI":"10.1161\/01.STR.0000131749.81508.18"},{"key":"2020022801102348200_R40","doi-asserted-by":"crossref","unstructured":"Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest1993;91:308-318.","DOI":"10.1172\/JCI116187"},{"key":"2020022801102348200_R41","doi-asserted-by":"crossref","unstructured":"Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A2000;97:2832-2835.","DOI":"10.1073\/pnas.97.6.2832"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/52\/1\/53\/32685226\/clinchem0053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/52\/1\/53\/32685226\/clinchem0053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T06:11:18Z","timestamp":1582870278000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/52\/1\/53\/5626608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2006,1,1]]},"published-print":{"date-parts":[[2006,1,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2005.057950","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2006,1,1]]},"published":{"date-parts":[[2006,1,1]]}}}